05:47:00 EDT Mon 15 Aug 2022
Enter Symbol
or Name

Login ID:
Avicanna Inc
Symbol AVCN
Shares Issued 45,858,596
Close 2021-11-25 C$ 0.69
Recent Sedar Documents

Medipharm, Avicanna export medical pot to Barbados

2021-11-26 07:25 ET - News Release

See News Release (C-LABS) Medipharm Labs Corp

Mr. Bryan Howcroft of Medipharm reports


Medipharm Labs Corp. has completed a medical cannabis export to Barbados in conjunction with strategic partner Avicanna Inc.

"Our GMP [good manufacturing practice] platform make us the go-to partner for companies looking to access global medical cannabis programs," said Bryan Howcroft, chief executive officer, Medipharm Labs. "As countries around the world continue to adopt medical cannabis programs, Medipharm Labs is best positioned to serve these markets as the only North American producer with a drug establishment licence (GMP) for the extraction of natural cannabinoids."

The company has manufactured and delivered Avicanna RHO Phyto products for the medical community and patients in the Caribbean through Bryden Stokes, an established health and pharmaceutical product distributor in the region. These advanced cannabis products are evidence based and marketed via the Avicanna educational platform, including patient support, marketing and training.

Medipharm Labs will continue to deliver to international jurisdictions with medical cannabis programs in place. This execution is a proof of concept for future pharmaceutical customers who select Medipharm Labs to manufacture novel and generic drugs with marketing authorization for physician prescriptions in regions like the United States and European Union.

About Medipharm Labs Corp.

Founded in 2015, Medipharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products utilizing a good manufacturing practices certified facility with International Organization for Standardization standard-built clean rooms. Medipharm Labs has invested in an expert, research-driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities with five primary extraction lines for delivery of pure, trusted and precision-dosed cannabis products for its customers. Through its wholesale and white label platforms, Medipharm Labs formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets.

We seek Safe Harbor.

© 2022 Canjex Publishing Ltd. All rights reserved.